Antifungal drugs are chemical compounds used to kill or inhibit the growth of fungi.These drugs act by various mechanisms such as the inhibition of cell division, the inhibition of cell wall formation, and cell membrane disruption.In this report, Technavio covers the present scenario and the growth prospects of the global antifungal drugs market for 2017-2021. To calculate the market size, the

report considers the revenue generated from the sales of branded, generics and OTC drugs used for the treatment and prevention of various fungal infections. The report also considers the revenue to be generated from the sales of drugs that are expected to be launched in the market along with the decline in revenue from the patent expiries of the marketed drugs during the forecast period.

PART 01: Executive summary 6

PART 02: Scope of the report 17

PART 03: Research Methodology 23

PART 04: Introduction 26

Key market highlights 26

PART 05: Market landscape 28

Market overview 28

Five forces analysis 36

PART 06: Market segmentation by ROA 37

Global oral antifungal drugs market 38

Global parenteral antifungal drugs market 38

Global topical antifungal drugs market 39

PART 07: Market segmentation by type 40

Global prescription antifungal drugs market 41

Global OTC antifungal drugs market 42

PART 08: Market segmentation by chemical class 43

PART 09: Geographical segmentation 44

Antifungal drugs market in Americas 46

Antifungal drugs market in the US 49

Antifungal drugs market in EMEA 50

Antifungal drugs market in Europe 52

Antifungal drugs market in APAC 53

Antifungal drugs market in Japan 56

PART 10: Market drivers 57

QIDP and other special regulatory designations 57

Increase in prevalence of infections and environmental

changes 58

Rising popularity of OTC antifungal drugs for dermal

infections 59

PART 11: Impact of drivers 60

PART 12: Market challenges 61

Antifungal drug resistance 61

Increased availability of generics and alternative

therapies 61

Poor patient adherence 62

PART 13: Impact of drivers and challenges 63

PART 14: Market trends 64

Increased funding for antifungal research 64

Increased focus on combination therapies 65

Incorporation of novel technology for product

development 65

Strategic alliances and M&A 65

PART 15: Vendor landscape 67

Competitive scenario 67

Other prominent vendors 70

PART 16: Key vendor analysis 75

Astellas Pharma 75

Johnson & Johnson 78

Merck 80

Novartis 83

Pfizer 87

PART 17: Appendix 89

List of abbreviations 89

PART 18: Explore Technavio 90